ISMP (US) Contact Us Feedback
     Search:  
   

ISMP Canada News

March 16, 2018: Health Canada: Zinbryta (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis


Health Canada: Zinbryta (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis" trackback:ping="https://www.ismp-canada.org/news/bblog/trackback.php/325/" />